$LRMR
Larimar Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Larimar Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is LRMR down today? It is at $2.88 (-2.48%), and our scanner flagged it 140 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LRMR spikes, and full due diligence on LRMR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LRMR 140 times in the last 30 days. Create a free account to track $LRMR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how LRMR traded in the last session, Friday (last price and move above). Our scanner fired 18 unusual-volume and momentum alerts on LRMR on Friday, peaking at 45.0x its normal volume.
Likely catalystLarimar Therapeutics, Inc.: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Nov 18, 2026 · 3 days agoThe company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
20,000,000 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Sherman Jeffrey W Director | Bought (open market) | +3K | added 66% | 8K | $10K at $3.06 | Nov 16, 26 |
Clayton Russell Officer | Bought (open market) | +3K | added 4.6% | 75K | $10K at $3.01 | Nov 16, 26 |
Hamilton Thomas Edward Director | Bought (open market) | +70K 0.07% of company | added 44% | 229K | $187K at $2.67 | Nov 12, 26 |
Shankar Gopi Officer | Bought (open market) | +5K | added 6.5% | 81K | $14K at $2.71 | Nov 11, 26 |
Celano Michael Officer | Bought (open market) | +18K 0.02% of company | added 8.6% | 234K | $50K at $2.71 | Nov 11, 26 |
Harlow John B. Jr. Officer | Bought (open market) | +18K 0.02% of company | added 36% | 68K | $50K at $2.80 | Nov 11, 26 |
Truitt Joseph Director | Bought (open market) | +4K | added 100% | 6K | $10K at $2.80 | Nov 11, 26 |
Thomas Frank E Director | Bought (open market) | +8K | added 100% | 15K | $22K at $2.73 | Nov 11, 26 |
Ben-Maimon Carole Officer | Bought (open market) | +18K 0.02% of company | added 4.9% | 386K | $50K at $2.77 | Nov 11, 26 |
Harlow John B. Jr. Officer | Acquired (grant/award) | +50K 0.05% of company | n/a | 50K | n/a | Sep 29, 26 |
Hamilton Thomas Edward Director | Bought (open market) | +50K 0.05% of company | added 7.5% | 715K | $167K at $3.34 | Jul 6, 26 |
Sherman Jeffrey W Director | Bought (open market) | +5K | n/a | 5K | $25K at $5.00 | Feb 27, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.


The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how LRMR traded in the last session, Friday (last price and move above). Our scanner fired 18 unusual-volume and momentum alerts on LRMR on Friday, peaking at 45.0x its normal volume.
LRMR last traded at $2.88, down 2.48% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The LRMR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LRMR 140 times in the last 30 days.
LRMR (Larimar Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $329M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LRMR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LRMR discussion
Sign in to ask a question or join the discussion.